Abstract. Our valence band photoelectron spectroscopic studies show a temperature dependent spectral weight transfer near the Fermi level in the Fe-based superconductor FeSe 1−x Te x . Using theoretical band structure calculations we have shown that the weight transfer is due to the temperature induced changes in the Fe(Se,Te) 4 tetrahedra. These structural changes lead to shifts in the electron occupancy from the xz/yz and x 2 -y 2 orbitals to the 3z 2 -r 2 orbitals indicating a temperature induced crossover from a metallic state to an Orbital Selective Mott (OSM) Phase. Our study presents the observation of a temperature induced crossover to a low temperature OSM phase in the family of Fe chalcogenides.
Temperature (12K ≤ T ≤ 300K) dependent extended X-ray absorption fine structure (EXAFS) studies at the Fe K edge in FeSe 1−x Te x (x = 0, 0.5 and 1.0) compounds have been carried out to understand the reasons for increase in T C upon Te doping in FeSe. While local distortions are present near superconducting onset in FeSe and FeSe 0.5 Te 0.5 , they seem to be absent in non superconducting FeTe. Of crucial importance is the variation of anion height. In FeSe 0.5 Te 0.5 , near superconducting onset, the two heights, h F e−Se and h F e−T e show a nearly opposite behaviour. These changes indicate a possible correlation between Fe-chalcogen hybridization and the superconducting transition temperature in these Fe-chalcogenides.
PACS numbers:
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.